FIVE PRIME THERAPEUTICS INC (32) | License Agreements (4)
Recent Contracts
-
Amendment No. 3 to the Non-Exclusive License Agreement by and among the company, BioWa, Inc. and Lonza Sales AG, dated as of July 17, 2019
(Filed With SEC on November 6, 2019)
-
Amendment No. 4 to the Non-Exclusive License Agreement by and among the company, BioWa, Inc. and Lonza Sales AG, dated as of August 22, 2019
(Filed With SEC on November 6, 2019)
-
Amendment No. 1 to the Non-Exclusive License Agreement by and among the company, BioWa, Inc. and Lonza Sales AG, dated as of June 6, 2013
(Filed With SEC on February 26, 2019)
-
Amendment No. 2 to the Non-Exclusive License Agreement by and among the company, BioWa, Inc. and Lonza Sales AG, dated as of April 27, 2018
(Filed With SEC on February 26, 2019)
